Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Terminated × Surgical Procedures, Operative × Clear all

Phase

Phase 2 26 Phase NA 10 Phase 3 10 Phase 1 6 Phase 1/2 3 Phase 2/3 1

Status

Unknown 4 Withdrawn 2 Recruiting 2 Not yet recruiting 2 Active not recruiting 2 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 8 Cisplatin 7 Carboplatin 7 Paclitaxel 6 Fluorouracil 6 Cyclophosphamide 6 Docetaxel 5 Capecitabine 5 Vinorelbine 3 Stem Cell Transplantation 3 Radiotherapy 3 Pemetrexed 3 Melphalan 3 Leucovorin 3 Granulocyte Colony-Stimulating Factor 3 Filgrastim 3 Etoposide 3 Bevacizumab 3 umbralisib 2 ublituximab 2 fludarabine 2 Trastuzumab 2 Transplantation, Homologous 2 Surveys and Questionnaires 2 S 1 (combination) 2 Oxaliplatin 2 Nivolumab 2 Mitomycin 2 Erlotinib Hydrochloride 2 Drug Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02326285 2018-01-23

NeoIntercal

AIO-Studien-gGmbH

Phase 2/3 Terminated

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡